Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway.
We had demonstrated that plasminogen kringle 5 (K5), a potent angiogenic inhibitor, inhibited retinal neovascularization and hepatocellular carcinoma growth by anti-angiogenesis. The current study investigated the effects and the underlying mechanisms of K5 on both tumor growth and spontaneous pulmo...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3534244?pdf=render |
_version_ | 1818262826362339328 |
---|---|
author | Wei-Bin Cai Yang Zhang Rui Cheng Zheng Wang Shu-Huan Fang Zu-Min Xu Xia Yang Zhong-Han Yang Jian-Xing Ma Chun-Kui Shao Guo-Quan Gao |
author_facet | Wei-Bin Cai Yang Zhang Rui Cheng Zheng Wang Shu-Huan Fang Zu-Min Xu Xia Yang Zhong-Han Yang Jian-Xing Ma Chun-Kui Shao Guo-Quan Gao |
author_sort | Wei-Bin Cai |
collection | DOAJ |
description | We had demonstrated that plasminogen kringle 5 (K5), a potent angiogenic inhibitor, inhibited retinal neovascularization and hepatocellular carcinoma growth by anti-angiogenesis. The current study investigated the effects and the underlying mechanisms of K5 on both tumor growth and spontaneous pulmonary metastasis in Lewis lung carcinoma (LLC) implanted mouse model. Similarly, K5 could decrease expression of VEGF in LLC cells and grafted tissues and suppress tumor angiogenesis and growth. K5 had no direct effect on proliferation and apoptosis of LLC. However, K5 could significantly inhibit SDF-1α-induced chemotaxis movement of LLC cells and resulted in a great reduction of surface metastatic nodules and micrometastases in the lungs of LLC tumor-bearing mice. K5 also decreased expression of chemokine (C-X-C motif) receptor 4 (CXCR4) in LLC cells and grafted tissues. Furthermore, K5 down-regulated SDF-1α expression in metastatic lung tissues of LLC-bearing mice. Therefore, K5 may suppress tumor pulmonary metastasis through inhibiting SDF-1α-CXCR4 chemotaxis movement and down-regulation of VEGF. Moreover, the role of hypoxia inducible factor-1α (HIF-1α), a crucial transcriptional factor for both VEGF and CXCR4 expression, was evaluated. The siRNA of HIF-1α attenuated expression of VEGF and CXCR4 and inhibited LLC migration. K5 decreased HIF-1α protein level and impaired nuclear HIF-1α accumulation. These results showed for the first time that K5 inhibits LLC growth and metastasis via the dual effects of anti-angiogenesis and suppression of tumor cell motility by targeting the pivotal molecule, HIF-1α. |
first_indexed | 2024-12-12T19:09:17Z |
format | Article |
id | doaj.art-42c6d1556ab64986a903095d92f21262 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-12T19:09:17Z |
publishDate | 2012-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-42c6d1556ab64986a903095d92f212622022-12-22T00:14:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5315210.1371/journal.pone.0053152Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway.Wei-Bin CaiYang ZhangRui ChengZheng WangShu-Huan FangZu-Min XuXia YangZhong-Han YangJian-Xing MaChun-Kui ShaoGuo-Quan GaoWe had demonstrated that plasminogen kringle 5 (K5), a potent angiogenic inhibitor, inhibited retinal neovascularization and hepatocellular carcinoma growth by anti-angiogenesis. The current study investigated the effects and the underlying mechanisms of K5 on both tumor growth and spontaneous pulmonary metastasis in Lewis lung carcinoma (LLC) implanted mouse model. Similarly, K5 could decrease expression of VEGF in LLC cells and grafted tissues and suppress tumor angiogenesis and growth. K5 had no direct effect on proliferation and apoptosis of LLC. However, K5 could significantly inhibit SDF-1α-induced chemotaxis movement of LLC cells and resulted in a great reduction of surface metastatic nodules and micrometastases in the lungs of LLC tumor-bearing mice. K5 also decreased expression of chemokine (C-X-C motif) receptor 4 (CXCR4) in LLC cells and grafted tissues. Furthermore, K5 down-regulated SDF-1α expression in metastatic lung tissues of LLC-bearing mice. Therefore, K5 may suppress tumor pulmonary metastasis through inhibiting SDF-1α-CXCR4 chemotaxis movement and down-regulation of VEGF. Moreover, the role of hypoxia inducible factor-1α (HIF-1α), a crucial transcriptional factor for both VEGF and CXCR4 expression, was evaluated. The siRNA of HIF-1α attenuated expression of VEGF and CXCR4 and inhibited LLC migration. K5 decreased HIF-1α protein level and impaired nuclear HIF-1α accumulation. These results showed for the first time that K5 inhibits LLC growth and metastasis via the dual effects of anti-angiogenesis and suppression of tumor cell motility by targeting the pivotal molecule, HIF-1α.http://europepmc.org/articles/PMC3534244?pdf=render |
spellingShingle | Wei-Bin Cai Yang Zhang Rui Cheng Zheng Wang Shu-Huan Fang Zu-Min Xu Xia Yang Zhong-Han Yang Jian-Xing Ma Chun-Kui Shao Guo-Quan Gao Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway. PLoS ONE |
title | Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway. |
title_full | Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway. |
title_fullStr | Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway. |
title_full_unstemmed | Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway. |
title_short | Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway. |
title_sort | dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting hif 1α pathway |
url | http://europepmc.org/articles/PMC3534244?pdf=render |
work_keys_str_mv | AT weibincai dualinhibitionofplasminogenkringle5onangiogenesisandchemotaxissuppressestumormetastasisbytargetinghif1apathway AT yangzhang dualinhibitionofplasminogenkringle5onangiogenesisandchemotaxissuppressestumormetastasisbytargetinghif1apathway AT ruicheng dualinhibitionofplasminogenkringle5onangiogenesisandchemotaxissuppressestumormetastasisbytargetinghif1apathway AT zhengwang dualinhibitionofplasminogenkringle5onangiogenesisandchemotaxissuppressestumormetastasisbytargetinghif1apathway AT shuhuanfang dualinhibitionofplasminogenkringle5onangiogenesisandchemotaxissuppressestumormetastasisbytargetinghif1apathway AT zuminxu dualinhibitionofplasminogenkringle5onangiogenesisandchemotaxissuppressestumormetastasisbytargetinghif1apathway AT xiayang dualinhibitionofplasminogenkringle5onangiogenesisandchemotaxissuppressestumormetastasisbytargetinghif1apathway AT zhonghanyang dualinhibitionofplasminogenkringle5onangiogenesisandchemotaxissuppressestumormetastasisbytargetinghif1apathway AT jianxingma dualinhibitionofplasminogenkringle5onangiogenesisandchemotaxissuppressestumormetastasisbytargetinghif1apathway AT chunkuishao dualinhibitionofplasminogenkringle5onangiogenesisandchemotaxissuppressestumormetastasisbytargetinghif1apathway AT guoquangao dualinhibitionofplasminogenkringle5onangiogenesisandchemotaxissuppressestumormetastasisbytargetinghif1apathway |